Market Research Logo

Japan Orthobiologics Market Outlook to 2025

Japan Orthobiologics Market Outlook to 2025

Summary

GlobalData’s new report, Japan Orthobiologics Market Outlook to 2025, provides key market data on the Japan Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Orthobiologics market categories - Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Orthobiologics market.
  • Global corporate-level profiles of key companies operating within the Japan Orthobiologics market.
  • Key players covered include Medtronic plc, Sanofi, Stryker Corp and Others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Orthobiologics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, Japan
3.1 Orthobiologics Market, Japan, Revenue ($m), 2015-2025
3.1.1 Bone Grafts and Substitutes Market, Japan, Revenue ($m), by Segment, 2015-2025
3.1.2 Bone Growth Stimulators Market, Japan, Revenue ($m), by Segment, 2015-2025
3.1.3 Soft Tissue Biologics Market, Japan, Revenue ($m), by Segment, 2015-2025
3.1.4 Viscosupplementation Market, Japan, Revenue ($m), by Segment, 2015-2025
3.2 Orthobiologics Market, Japan, Volume (Units), 2015-2025
3.2.1 Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2015-2025
3.2.2 Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2015-2025
3.2.3 Soft Tissue Biologics Market, Japan, Volume (Units), by Segment, 2015-2025
3.2.4 Viscosupplementation Market, Japan, Volume (Units), by Segment, 2015-2025
3.3 Orthobiologics Market, Japan, Average Price ($), 2015-2025
3.4 Orthobiologics Market, Japan, Distribution Share by Revenue ($m), 2017
3.5 Orthobiologics Market, Japan, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in Japan, Orthobiologics Market
4.1 Seikagaku Corp
4.1.1 Company Overview
4.2 Chugai Pharmaceutical Co Ltd
4.2.1 Company Overview
4.3 DePuy Synthes Inc
4.3.1 Company Overview
4.4 Stryker Corp
4.4.1 Company Overview
4.5 Medtronic Plc
4.5.1 Company Overview
4.6 Sanofi
4.6.1 Company Overview
4.7 Zimmer Biomet Holdings Inc
4.7.1 Company Overview
5 Orthobiologics Market Pipeline Products
6 Financial Deals Landscape
6.1 Partnerships
6.1.1 Medinet Enters into Licensing Agreement with Histogenics
7 Recent Developments
7.1 Financial Announcements
7.1.1 Apr 26, 2018: Kyocera Announces Financial Results for Year Ended March 31, 2018
7.1.2 Mar 29, 2018: Mesoblast Phase 3 Cell Therapy Trial for Chronic Low Back Pain Completes Enrollment
7.1.3 Mar 28, 2018: Ipsen Announces EMA Validation of Filing of a New Application for Additional Indication for Cabometyx, for patients with previously treated advanced Hepatocellular Carcinoma (HCC)
7.1.4 Mar 27, 2018: Constant Pharmaceuticals Announces European Patent Issuance for TXA127 in Treatment of Stroke
7.1.5 Mar 22, 2018: SelectHealth Signs Value-based Contract With Novo Nordisk
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Orthobiologics Market, Japan, Revenue ($m), USD Constant, 2015-2020
Table 2: Orthobiologics Market, Japan, Revenue ($m), USD Constant, 2021-2025
Table 3: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, 2015-2020
Table 4: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, 2021-2025
Table 5: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, 2015-2020
Table 6: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, 2021-2025
Table 7: Soft Tissue Biologics Market, Japan, Revenue ($m), USD Constant, 2015-2020
Table 8: Soft Tissue Biologics Market, Japan, Revenue ($m), USD Constant, 2021-2025
Table 9: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, 2015-2020
Table 10: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, 2021-2025
Table 11: Orthobiologics Market, Japan, Volume (Units), 2015-2020
Table 12: Orthobiologics Market, Japan, Volume (Units), 2021-2025
Table 13: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2015-2020
Table 14: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2021-2025
Table 15: Bone Growth Stimulators Market, Japan, Volume (Units), 2015-2020
Table 16: Bone Growth Stimulators Market, Japan, Volume (Units), 2021-2025
Table 17: Soft Tissue Biologics Market, Japan, Volume (Units), 2015-2020
Table 18: Soft Tissue Biologics Market, Japan, Volume (Units), 2021-2025
Table 19: Viscosupplementation Market, Japan, Volume (Units), 2015-2020
Table 20: Viscosupplementation Market, Japan, Volume (Units), 2021-2025
Table 21: Orthobiologics Market, Japan, Average Price ($), 2015-2020
Table 22: Orthobiologics Market, Japan, Average Price ($), 2021-2025
Table 23: Orthobiologics Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2017
Table 24: Orthobiologics Market, Japan, Company Share by Revenue ($m), USD Constant, 2017
Table 25: Orthobiologics Market Pipeline Products
Table 26: Medinet Enters into Licensing Agreement with Histogenics
Table 27: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
1.2 List of Figures
Figure 1: Orthobiologics Market, Japan, Revenue ($m), USD Constant, 2015-2025
Figure 2: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, 2015-2025
Figure 3: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, 2015-2025
Figure 4: Soft Tissue Biologics Market, Japan, Revenue ($m), USD Constant, 2015-2025
Figure 5: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, 2015-2025
Figure 6: Orthobiologics Market, Japan, Volume (Units), 2015-2025
Figure 7: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2015-2025
Figure 8: Bone Growth Stimulators Market, Japan, Volume (Units), 2015-2025
Figure 9: Soft Tissue Biologics Market, Japan, Volume (Units), 2015-2025
Figure 10: Viscosupplementation Market, Japan, Volume (Units), 2015-2025
Figure 11: Orthobiologics Market, Japan, Company Share (%) 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report